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LIGHT/TNFSF14, a member of the tumor necrosis factor superfamily, is known 
to play a major role in T-cell homeostasis, whereas its effect on osteoclastogenesis 
is controversial. Here, we investigated LIGHT involvement in bone cell differentia-
tion as well as in the bone-disease associated to Multiple Myeloma (MM), a plasma 
cell malignancies. We showed that LIGHT pro-osteoclastogenic effect can be exert-
ed in a RANKL-independent and -dependent way. Regarding the last condition, at 
sub-optimal RANKL dose, the two molecules synergically increased osteoclastogen-
esis, due to an early and sustained Akt, NF-kB and JNK phophorylation if compared 
with cultures treated with RANKL or LIGHT alone. Further, we found that LIGHT 
did not directly affect osteoblastogenesis in cultures of mesenchymal stem cells 
(MSCs). Conversely, LIGHT indirectly impaired osteoblasto-genesis in the co-culture 
of MSCs with monocytes plus T-cells, or with monocytes alone. Indeed in LIGHT 
treated co-cultures, we found significant lower levels of alkaline phos-phatase (ALP) 
and Collagen-I mRNA than in untreated cultures. Surprisingly, we showed that the 
high sclerostin expression by monocytes can be related to LIGHT inhibitory effect on 
osteoblastogenesis. Regarding MM-bone disease patients, we found to express higher 
LIGHT levels on CD14+ monocytes, CD8+ T cells and CD16+ neutrophils compared 
to the same cells from controls. Moreover, in bone marrow derived opportune cul-
tures from MM-bone disease patients the addition of anti-LIGHT antibody dose-
dependently inhibited osteoclastogenesis as well as it promoted osteoblastogenesis, as 
shown by the increase of CFU-OBs and by the up-regulation of Osterix, ALP, Colla-
gen-I, Bone Sialoprotein and Osteocalcin expression. In conclusion, our data showed 
LIGHT involvement in bone cell differentiation and in MM-bone disease, highlight-
ing it as a new promising target for the management of MM-bone disease and prob-
ably of other osteolytic pathologies.
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